
Middle East Carbon Dioxide Market Size, Share, Trends, Industry Analysis Report By Source (Hydrogen, Ethyl Alcohol, Ethylene Oxide, Substitute Natural Gas, Others), By Application, By Country – Market Forecast, 2025–2034
Description
The middle east carbon dioxide market size is expected to reach USD 2.29 billion by 2034, according to a new study by Polaris Market Research. The report “Middle East Carbon Dioxide Market Share, Size, Trends, Industry Analysis Report By Source (Hydrogen, Ethyl Alcohol, Ethylene Oxide, Substitute Natural Gas, Others), By Application, By Country; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Carbon dioxide (CO2) is a naturally occurring, colorless gas critical to life on Earth. It is a key component of the planet's carbon cycle and a primary greenhouse gas that traps heat in the atmosphere. It is also used in carbonated beverages, fire extinguishers, as a refrigerant, and in enhanced oil recovery to extract more crude from wells.
The Middle East is a significant contributor to CO2 emissions, primarily due to its extensive hydrocarbon-based economy. The region's arid climate also necessitates substantial energy consumption for water desalination and cooling, resulting in increased CO2 emissions. Gulf nations such as Saudi Arabia and the UAE are investing heavily in carbon capture, utilization, and storage (CCUS) technologies and renewable energy projects, such as NEOM and Masdar City, to diversify their economies and mitigate their substantial carbon footprint.
Middle East CO2 Market Report Highlights
In terms of source, the ethyl alcohol segment accounted for a major revenue share in 2024 due to its extensive use in food and beverages, pharmaceuticals, and industrial applications.
The substitute natural gas segment is projected to grow at a robust pace in the coming years, owing to the rising energy diversification initiatives and increasing adoption of alternative fuels.
Based on application, the food & beverages segment held the largest revenue share in 2024 due to expanding consumption of carbonated drinks, packaged foods, and processed products.
The oil & gas segment is projected to grow at a rapid pace during the forecast period, owing to the increasing use of CO2 in enhanced oil recovery (EOR) projects.
Saudi Arabia held the largest Middle East carbon dioxide (CO2) market share in 2024. This dominance is attributed to its strong industrial base and high consumption of CO2 across food processing, beverages, oil and gas, and medical applications.
The UAE market is projected to hold a substantial revenue share by 2034, driven by increasing investments in industrial gases and carbon capture, utilization, and storage (CCUS) projects.
A few key market players include ADNOC; Air Liquide; Air Products and Chemicals, Inc.; Aramco; EIG; Gulf Cryo; Linde PLC; SABIC; Sicgil; and Technip Energies.
Polaris Market Research has segmented the CO2 market report on the basis of source, application, and country:
By Source Outlook (Revenue, USD Billion, Volume Kiloton, 2020–2034)
Hydrogen
Ethyl Alcohol
Ethylene Oxide
Substitute Natural Gas
Others
By Application Outlook (Revenue, USD Billion, Volume Kiloton, 2020–2034)
Food & Beverages
Oil & Gas
Medical
Rubber
Firefighting
Others
By Country Outlook (Revenue, USD Billion, Volume Kiloton, 2020–2034)
Saudi Arabia
UAE
Qatar
Israel
Rest of Middle East
Carbon dioxide (CO2) is a naturally occurring, colorless gas critical to life on Earth. It is a key component of the planet's carbon cycle and a primary greenhouse gas that traps heat in the atmosphere. It is also used in carbonated beverages, fire extinguishers, as a refrigerant, and in enhanced oil recovery to extract more crude from wells.
The Middle East is a significant contributor to CO2 emissions, primarily due to its extensive hydrocarbon-based economy. The region's arid climate also necessitates substantial energy consumption for water desalination and cooling, resulting in increased CO2 emissions. Gulf nations such as Saudi Arabia and the UAE are investing heavily in carbon capture, utilization, and storage (CCUS) technologies and renewable energy projects, such as NEOM and Masdar City, to diversify their economies and mitigate their substantial carbon footprint.
Middle East CO2 Market Report Highlights
In terms of source, the ethyl alcohol segment accounted for a major revenue share in 2024 due to its extensive use in food and beverages, pharmaceuticals, and industrial applications.
The substitute natural gas segment is projected to grow at a robust pace in the coming years, owing to the rising energy diversification initiatives and increasing adoption of alternative fuels.
Based on application, the food & beverages segment held the largest revenue share in 2024 due to expanding consumption of carbonated drinks, packaged foods, and processed products.
The oil & gas segment is projected to grow at a rapid pace during the forecast period, owing to the increasing use of CO2 in enhanced oil recovery (EOR) projects.
Saudi Arabia held the largest Middle East carbon dioxide (CO2) market share in 2024. This dominance is attributed to its strong industrial base and high consumption of CO2 across food processing, beverages, oil and gas, and medical applications.
The UAE market is projected to hold a substantial revenue share by 2034, driven by increasing investments in industrial gases and carbon capture, utilization, and storage (CCUS) projects.
A few key market players include ADNOC; Air Liquide; Air Products and Chemicals, Inc.; Aramco; EIG; Gulf Cryo; Linde PLC; SABIC; Sicgil; and Technip Energies.
Polaris Market Research has segmented the CO2 market report on the basis of source, application, and country:
By Source Outlook (Revenue, USD Billion, Volume Kiloton, 2020–2034)
Hydrogen
Ethyl Alcohol
Ethylene Oxide
Substitute Natural Gas
Others
By Application Outlook (Revenue, USD Billion, Volume Kiloton, 2020–2034)
Food & Beverages
Oil & Gas
Medical
Rubber
Firefighting
Others
By Country Outlook (Revenue, USD Billion, Volume Kiloton, 2020–2034)
Saudi Arabia
UAE
Qatar
Israel
Rest of Middle East
Table of Contents
125 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Neurology Clinical Trials Market Insights
- 4.1. Neurology Clinical Trials Market – Market Snapshot
- 4.2. Neurology Clinical Trials Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence of Neurological Disorders
- 4.2.1.2. Increase in Government Funding and Support
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High trial failure rates due to the complexity
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Neurology Clinical Trials Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Neurology Clinical Trials Market, by Phase
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 5.3. Phase I
- 5.3.1. Global Neurology Clinical Trials Market, by Phase I, by Region, 2020–2034 (USD Billion)
- 5.4. Phase II
- 5.4.1. Global Neurology Clinical Trials Market, by Phase II, by Region, 2020–2034 (USD Billion)
- 5.5. Phase III
- 5.5.1. Global Neurology Clinical Trials Market, by Phase III, by Region, 2020–2034 (USD Billion)
- 5.6. Phase IV
- 5.6.1. Global Neurology Clinical Trials Market, by Phase IV, by Region, 2020–2034 (USD Billion)
- 6. Global Neurology Clinical Trials Market, by Study Design
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 6.3. Interventional
- 6.3.1. Global Neurology Clinical Trials Market, by Interventional, by Region, 2020–2034 (USD Billion)
- 6.4. Observational
- 6.4.1. Global Neurology Clinical Trials Market, by Observational, by Region, 2020–2034 (USD Billion)
- 6.5. Expanded Access
- 6.5.1. Global Neurology Clinical Trials Market, by Expanded Access, by Region, 2020–2034 (USD Billion)
- 7. Global Neurology Clinical Trials Market, by Indication
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 7.3. Alzheimer’s Disease
- 7.3.1. Global Neurology Clinical Trials Market, by Alzheimer’s Disease, by Region, 2020–2034 (USD Billion)
- 7.4. Depression (MDD)
- 7.4.1. Global Neurology Clinical Trials Market, by Depression (MDD), by Region, 2020–2034 (USD Billion)
- 7.5. Parkinson's Disease (PD)
- 7.5.1. Global Neurology Clinical Trials Market, by Parkinson's Disease (PD), by Region, 2020–2034 (USD Billion)
- 7.6. Epilepsy
- 7.6.1. Global Neurology Clinical Trials Market, by Epilepsy, by Region, 2020–2034 (USD Billion)
- 7.7. Stroke
- 7.7.1. Global Neurology Clinical Trials Market, by Stroke, by Region, 2020–2034 (USD Billion)
- 7.8. Traumatic Brain Injury (TBI)
- 7.8.1. Global Neurology Clinical Trials Market, by Traumatic Brain Injury (TBI), by Region, 2020–2034 (USD Billion)
- 7.9. Amyotrophic Lateral Sclerosis (ALS)
- 7.9.1. Global Neurology Clinical Trials Market, by Amyotrophic Lateral Sclerosis (ALS), by Region, 2020–2034 (USD Billion)
- 7.10. Huntington's Disease
- 7.10.1. Global Neurology Clinical Trials Market, by Huntington's Disease, by Region, 2020–2034 (USD Billion)
- 7.11. Muscle Regeneration
- 7.11.1. Global Neurology Clinical Trials Market, by Muscle Regeneration, by Region, 2020–2034 (USD Billion)
- 7.12. Others
- 7.12.1. Global Neurology Clinical Trials Market, by Others, by Region, 2020–2034 (USD Billion)
- 8. Global Neurology Clinical Trials Market, by Value Chain
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 8.3. In-house
- 8.3.1. Global Neurology Clinical Trials Market, by In-house, by Region, 2020–2034 (USD Billion)
- 8.4. CROs
- 8.4.1. Global Neurology Clinical Trials Market, by CROs, by Region, 2020–2034 (USD Billion)
- 8.5. Investigator Sites/Clinical Sites
- 8.5.1. Global Neurology Clinical Trials Market, by Investigator Sites/Clinical Sites, by Region, 2020–2034 (USD Billion)
- 9. Global Neurology Clinical Trials Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Neurology Clinical Trials Market Assessment, By Geography, 2020–2034 (USD Billion)
- 9.3. Neurology Clinical Trials Market – North America
- 9.3.1. North America: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.3.2. North America: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.3.3. North America: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.3.4. North America: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.3.5. Neurology Clinical Trials Market – US
- 9.3.5.1. US: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.3.5.2. US: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.3.5.3. US: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.3.5.4. US: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.3.6. Neurology Clinical Trials Market – Canada
- 9.3.6.1. Canada: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.3.6.2. Canada: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.3.6.3. Canada: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.3.6.4. Canada: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.4. Neurology Clinical Trials Market – Europe
- 9.4.1. Europe: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.4.2. Europe: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.4.3. Europe: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.4.4. Europe: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.4.5. Neurology Clinical Trials Market – UK
- 9.4.5.1. UK: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.4.5.2. UK: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.4.5.3. UK: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.4.5.4. UK: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.4.6. Neurology Clinical Trials Market – France
- 9.4.6.1. France: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.4.6.2. France: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.4.6.3. France: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.4.6.4. France: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.4.7. Neurology Clinical Trials Market – Germany
- 9.4.7.1. Germany: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.4.7.2. Germany: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.4.7.3. Germany: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.4.7.4. Germany: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.4.8. Neurology Clinical Trials Market – Italy
- 9.4.8.1. Italy: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.4.8.2. Italy: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.4.8.3. Italy: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.4.8.4. Italy: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.4.9. Neurology Clinical Trials Market – Spain
- 9.4.9.1. Spain: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.4.9.2. Spain: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.4.9.3. Spain: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.4.9.4. Spain: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.4.10. Neurology Clinical Trials Market – Netherlands
- 9.4.10.1. Netherlands: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.4.10.2. Netherlands: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.4.10.3. Netherlands: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.4.10.4. Netherlands: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.4.11. Neurology Clinical Trials Market – Russia
- 9.4.11.1. Russia: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.4.11.2. Russia: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.4.11.3. Russia: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.4.11.4. Russia: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.4.12. Neurology Clinical Trials Market – Rest of Europe
- 9.4.12.1. Rest of Europe: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.4.12.2. Rest of Europe: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.4.12.3. Rest of Europe: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.4.12.4. Rest of Europe: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.5. Neurology Clinical Trials Market – Asia Pacific
- 9.5.1. Asia Pacific: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.5.2. Asia Pacific: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.5.3. Asia Pacific: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.5.4. Asia Pacific: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.5.5. Neurology Clinical Trials Market – China
- 9.5.5.1. China: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.5.5.2. China: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.5.5.3. China: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.5.5.4. China: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.5.6. Neurology Clinical Trials Market – India
- 9.5.6.1. India: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.5.6.2. India: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.5.6.3. India: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.5.6.4. India: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.5.7. Neurology Clinical Trials Market – Malaysia
- 9.5.7.1. Malaysia: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.5.7.2. Malaysia: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.5.7.3. Malaysia: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.5.7.4. Malaysia: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.5.8. Neurology Clinical Trials Market – Japan
- 9.5.8.1. Japan: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.5.8.2. Japan: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.5.8.3. Japan: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.5.8.4. Japan: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.5.9. Neurology Clinical Trials Market – Indonesia
- 9.5.9.1. Indonesia: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.5.9.2. Indonesia: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.5.9.3. Indonesia: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.5.9.4. Indonesia: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.5.10. Neurology Clinical Trials Market – South Korea
- 9.5.10.1. South Korea: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.5.10.2. South Korea: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.5.10.3. South Korea: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.5.10.4. South Korea: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.5.11. Neurology Clinical Trials Market – Australia
- 9.5.11.1. Australia: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.5.11.2. Australia: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.5.11.3. Australia: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.5.11.4. Australia: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.5.12. Neurology Clinical Trials Market – Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.5.12.2. Rest of Asia Pacific: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.5.12.3. Rest of Asia Pacific: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.5.12.4. Rest of Asia Pacific: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.6. Neurology Clinical Trials Market – Middle East & Africa
- 9.6.1. Middle East & Africa: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.6.2. Middle East & Africa: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.6.3. Middle East & Africa: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.6.4. Middle East & Africa: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.6.5. Neurology Clinical Trials Market – Saudi Arabia
- 9.6.5.1. Saudi Arabia: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.6.5.2. Saudi Arabia: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.6.5.3. Saudi Arabia: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.6.5.4. Saudi Arabia: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.6.6. Neurology Clinical Trials Market – UAE
- 9.6.6.1. UAE: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.6.6.2. UAE: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.6.6.3. UAE: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.6.6.4. UAE: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.6.7. Neurology Clinical Trials Market – Israel
- 9.6.7.1. Israel: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.6.7.2. Israel: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.6.7.3. Israel: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.6.7.4. Israel: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.6.8. Neurology Clinical Trials Market – South Africa
- 9.6.8.1. South Africa: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.6.8.2. South Africa: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.6.8.3. South Africa: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.6.8.4. South Africa: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.6.9. Neurology Clinical Trials Market – Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.6.9.2. Rest of Middle East & Africa: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.6.9.3. Rest of Middle East & Africa: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.6.9.4. Rest of Middle East & Africa: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.7. Neurology Clinical Trials Market – Latin America
- 9.7.1. Latin America: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.7.2. Latin America: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.7.3. Latin America: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.7.4. Latin America: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.7.5. Neurology Clinical Trials Market – Mexico
- 9.7.5.1. Mexico: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.7.5.2. Mexico: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.7.5.3. Mexico: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.7.5.4. Mexico: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.7.6. Neurology Clinical Trials Market – Brazil
- 9.7.6.1. Brazil: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.7.6.2. Brazil: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.7.6.3. Brazil: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.7.6.4. Brazil: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.7.7. Neurology Clinical Trials Market – Argentina
- 9.7.7.1. Argentina: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.7.7.2. Argentina: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.7.7.3. Argentina: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.7.7.4. Argentina: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 9.7.8. Neurology Clinical Trials Market – Rest of Latin America
- 9.7.8.1. Rest of Latin America: Neurology Clinical Trials Market, by Phase, 2020–2034 (USD Billion)
- 9.7.8.2. Rest of Latin America: Neurology Clinical Trials Market, by Study Design, 2020–2034 (USD Billion)
- 9.7.8.3. Rest of Latin America: Neurology Clinical Trials Market, by Indication, 2020–2034 (USD Billion)
- 9.7.8.4. Rest of Latin America: Neurology Clinical Trials Market, by Value Chain, 2020–2034 (USD Billion)
- 10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
- 11. Company Profiles
- 11.1. Biogen
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Charles River Laboratories
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Eisai Co., Ltd.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. ICON plc
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. IQVIA
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Laboratory Corporation of America Holdings
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Medpace Holdings, Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Parexel
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Pfizer Inc.
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Syneos Health
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Thermo Fisher Scientific
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.